Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

RemSleep Holdings (RMSL) Research & Development (2022 - 2025)

RemSleep Holdings' Research & Development history spans 5 years, with the latest figure at $1500.0 for Q2 2025.

  • Quarterly results put Research & Development at $1500.0 for Q2 2025, down 98.86% from a year ago — trailing twelve months through Sep 2025 was $9350.0 (down 97.66% YoY), and the annual figure for FY2024 was $187445.0, down 36.42%.
  • Research & Development for Q2 2025 was $1500.0 at RemSleep Holdings, down from $17200.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $205220.0 in Q4 2023 to a low of -$9350.0 in Q4 2024.
  • The 4-year median for Research & Development is $32416.5 (2022), against an average of $59727.5.
  • Peak annual rise in Research & Development hit 193.62% in 2024, while the deepest fall reached 104.56% in 2024.
  • Year by year, Research & Development stood at $152145.0 in 2022, then skyrocketed by 34.88% to $205220.0 in 2023, then crashed by 104.56% to -$9350.0 in 2024, then skyrocketed by 116.04% to $1500.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $1500.0, $17200.0, and -$9350.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.